Worldwide Clinical Trials adds Catalyst Clinical to global CRO mixture

Worldwide signed an agreement to acquire Catalyst Clinical Research. The combination will add key functional service provider capabilities, deliver immediate uplift in oncology, strengthen global site reach, and accelerate technology integration – enhancing speed, transparency, and value for customers. Read more in Fierce Biotech here.